Relaxin and phosphodiesterases collaborate during decidualization

Area of Science:

• Reproductive biology
• Cellular signaling
• Endocrinology

Background:

• The endometrium's primary role is embryo implantation.
• Decidualization, a key process in early pregnancy, involves endometrial stromal cell differentiation.
• Sustained intracellular cyclic adenosine monophosphate (cAMP) levels are vital for in vivo decidualization.

Purpose of the Study:

• To investigate if modulating phosphodiesterase (PDE) activity can enhance decidualization in human endometrial stromal cells.
• To explore the role of PDE inhibition in regulating intracellular cAMP levels during decidualization.

Main Methods:

• Cultured human endometrial stromal cells were treated with relaxin and a specific PDE4 inhibitor (rolipram).
• Intracellular cAMP levels were measured after acute (20 min) and long-term (3 days) treatments.
• Decidualization was assessed morphologically and by quantifying the expression of specific gene transcripts (prolactin and insulin-like growth factor binding protein-1).

Main Results:

• Relaxin combined with PDE4 inhibition (rolipram) significantly increased intracellular cAMP levels, both acutely and chronically.
• A synergistic effect on the decidualization phenotype was observed, with enhanced morphological changes and increased production of prolactin and insulin-like growth factor binding protein-1.
• cAMP levels were further elevated when negative feedback mechanisms were blocked, suggesting complex cAMP regulation.

Conclusions:

• Relaxin and PDE4 inhibition act synergistically to sustain elevated intracellular cAMP concentrations during decidualization.
• This coordinated action is essential for creating a receptive maternal interface for blastocyst implantation.
• Targeting PDE activity represents a potential strategy to support early pregnancy establishment.